| Bouwinvest Real Estate Investors
|
View online |
|
|
|
Newsletter #3
December 2020 |
|
|
|
| |
|
|
| |
|
|
| International strategy spearheads niche segments |
Bouwinvest’s participation in Blackstone’s recapitalisation of BioMed Realty illustrates the type of niche segment Bouwinvest is targeting as part of its goal to create value in both financial and social terms and add ‘Real value for life’, says Stephen Tross, CIO International Investments, in an interview on the company’s international strategy.
“Life science is very much top of mind in the Covid-19 era and there’s a huge amount of interest in biomedical research facilities. We expect to focus more on this niche which caters to all those parties dealing with innovative and creative developments such as Covid-19 vaccines and other medical treatments and cures which can really make a difference in our world.”
To achieve its growth strategy, Bouwinvest has opened offices in Sydney and New York. “We use our satellite offices mainly for three things: networking, deal sourcing and managing our existing investments. They allow us to be more integrated into the local communities and in more frequent contact with the managers we work with who are often located in the same cities, or in any case the same time zones. Having people on the ground helps us to put more controls in place, to extend our heavy emphasis on sustainability to our international portfolio and to meet the highest standards in terms of risk management and reporting. We have made some very good progress on all these fronts.” Read the full interview with Stephen on our website. |
|
|
|
|
|
| Investing in niche segments |
is part of our goal to reach
Real Value for Life. |
 |
|
| Stephen Tross |
| Chief investment officer international investments |
|
|
|
|
|
|
|
| |
|
|
| Bouwinvest publishes 2021-2023 Real Estate Market Outlook |
The dramatic ‘demand shock’ to the Dutch economy from the Covid-19 pandemic has had a widely varying impact on real estate investment sectors. Most, however, have proven resilient and are expected to recover and show healthy and stable growth once the pandemic is behind us. While many industries and economic sectors are experiencing stress, real estate continues to attract new investors thanks to generally supportive fundamentals and broadly favourable long-term market prospects relative to other investment asset classes, both in the Netherlands and globally.
From an economic perspective, the Netherlands found itself in a relatively sound position pre-Covid-19 compared to many other countries in Europe, due to its tradition of innovation, strong IT infrastructure and relatively low dependency on global tourism. The Bouwinvest Research team believes the Dutch market can also profit from this in the recovery phase, but the economic outlook for the Netherlands remains uncertain and Bouwinvest’s Real Estate Market Outlook 2021-2023 therefore provides three alternatives. Of these, the baseline and the downside scenario including extended (partial) lockdown measures are rated as the most likely. |
|
|
|
|
|
 |
| Bouwinvest gains record number of five-star GRESB rankings for Dutch investment fund vehicles |
Dutch institutional real estate manager Bouwinvest Real Estate Investors once again delivered a stellar sustainability performance in this year’s Global Real Estate Sustainability Benchmark (GRESB) rankings compared with 2019, with its Dutch Residential Fund and Dutch Hotel Fund awarded five stars, the highest possible rating, for the first time.
Each of the Dutch funds focusing on residential, office, retail, hotels and healthcare generated an above-average score compared with their international peers, according to GRESB’s latest results. Bouwinvest’s Dutch Office Fund has had a five-star ranking for several years and this year the Office Fund as well as the Hotel Fund were distinguished as Global Sector Leaders. Bouwinvest’s Dutch Retail and Dutch Healthcare Fund were awarded four stars as in previous years.
Thanks to these improvements, Bouwinvest is on track towards its goal of achieving an above-average sustainability rating by 2021 for 80% of its investments, which total more than €12.9 billion of invested capital worldwide.
|
|
|
|
|
|
 |
| Bouwinvest invests $60 million in US life science offices via Blackstone's BioMed Realty |
Bouwinvest has invested $60 million in life science office buildings across the United States on behalf of its North America Mandate. Bouwinvest’s participation in Blackstone’s recapitalisation of BioMed Realty brings it closer to its goal of growing its North American portfolio to $2 billion by 2022, from $1.65 billion currently.
Life science real estate in the US is experiencing solid demand fuelled by growth in publicly and privately funded biomedical research. BioMed’s assets are primarily located in the top-tier life science clusters in Boston, San Francisco, San Diego and Seattle, where biomedical companies in close proximity to medical universities and hospitals are able to tap into the local talent pool.
|
|
|
|
|
|
|
|
| We are proud that our Dutch sector funds |
| are among the most sustainable real estate funds worldwide. |
 |
|
| Mark Siezen |
| Chief Client Officer |
|
|
|
|
|
|
|
|
|
